Nushama

At the second edition of Benzinga’s Psychedelics Capital Conference, held in sunny Miami, leaders from four major ketamine therapy companies shared their optimistic insights and guidance about the industry. Revitalist L&W’s Kathryn Walker (OTC: RVLWF), Jeffrey Becker (Bexson...

This is the third article of a three-part series, you can find the first and second stories here.  Ketamine-assisted therapy has been in the headlines lately as several clinics have closed down and others reaffirmed they are continuing to be providers of these services. ...

Psychedelics Reform Update: 22 States Where Proposals Are Being Discussed & Local Moves Considered In the first months of 2023, state-level psychedelics policy reform has been so constant that it is hard to view it as a passing trend. While the first reported legalization proposal was a pre-...

In light of the latest news regarding the DEA’s telehealth regulations and the closing of two renowned ketamine clinics with facilities in the U.S., Benzinga had the opportunity to interview Jay Godfrey, co-founder of the NYC-based ketamine-assisted therapy...

(Part one of three.) In view of the latest news regarding the DEA’s telehealth regulations and the closing of two renowned ketamine clinics with facilities in the U.S., Benzinga had the opportunity to interview Jay Godfrey, co-founder of the NYC-based ketamine-assisted therapy...

NYC-based clinics brand Nushama has partnered with Awakn Life Sciences (OTCQB: AWKNF), a clinical-stage psychedelics biotech company to bring Awakn’s advanced ketamine-assisted therapy treatment for AUD to Nushama’s New York clinics. They intend to provide sustained...

Psychedelic-Assisted Therapy, or PAT, is the type of treatment in which the delivery of a psychedelic substance -i.e. ketamine, MDMA, psilocybin, DMT- is regularly paired with psychotherapy by a trained therapist to help produce long-lasting effects in individuals suffering from an ample array of...